Solid Biosciences (SLDB) Retained Earnings (2017 - 2026)
Solid Biosciences' (SLDB) quarterly Retained Earnings came in at -$13000.0 in Q1 2026, down 750.0% year-on-year from $2000.0 in Q1 2025, and up 100.0% quarter-over-quarter from -$957.8 million in Q4 2025.
Solid Biosciences (SLDB) Retained Earnings (2017 - 2026) Analysis & Trends
Solid Biosciences has disclosed Retained Earnings across 10 years of filings, most recently posting -$13000.0 for Q1 2026.
- Retained Earnings for Q1 2026 came in at -$13000.0, down 750.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$13000.0 (down 750.0% YoY), and the FY2025 annual result was -$957.8 million, down 2037919.15% from the prior year.
- Retained Earnings came in at -$13000.0 for Q1 2026 at Solid Biosciences, up from -$957.8 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $48000.0 in Q3 2025 to a low of -$957.8 million in Q4 2025.
- The 5-year median for Retained Earnings is -$527.2 million (2022), against an average of -$381.5 million.
- Peak annual rise in Retained Earnings reached 213.33% in 2024, while the deepest fall reached 13662100.0% in 2024.
- Solid Biosciences' Retained Earnings stood at -$562.7 million in 2022, then surged by 100.0% to $15000.0 in 2023, then surged by 213.33% to $47000.0 in 2024, then tumbled by 2037919.15% to -$957.8 million in 2025, then surged by 100.0% to -$13000.0 in 2026.
- The last three Retained Earnings figures came in at -$13000.0 (Q1 2026), -$957.8 million (Q4 2025), and $48000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -279.00 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | 130.89 Mn |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -838.07 Mn |
| 10 | Solid Biosciences | 789.54 Mn | 408.86 Mn | - | -13,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13,000.00 |
| Dec 31, 2025 | -957.78 Mn |
| Sep 30, 2025 | 48,000.00 |
| Jun 30, 2025 | -38,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Dec 31, 2024 | 47,000.00 |
| Sep 30, 2024 | -740.90 Mn |
| Jun 30, 2024 | -708.10 Mn |
| Mar 31, 2024 | -683.10 Mn |
| Dec 31, 2023 | 15,000.00 |
| Sep 30, 2023 | -638.42 Mn |
| Jun 30, 2023 | -617.44 Mn |
| Mar 31, 2023 | 5,000.00 |
| Dec 31, 2022 | -562.74 Mn |
| Sep 30, 2022 | -547.59 Mn |
| Jun 30, 2022 | -527.18 Mn |
| Mar 31, 2022 | -502.09 Mn |
| Dec 31, 2021 | -476.76 Mn |
| Sep 30, 2021 | -458.15 Mn |
| Jun 30, 2021 | -440.16 Mn |